stella
beta
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance — Stella
Home
/
Hepatocellular Carcinoma (HCC)
/
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
View on ClinicalTrials.gov
Recruiting
Back to Hepatocellular Carcinoma (HCC) trials
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
Trial locations
(1 site)
China
Tongji Hospital, Wuhan, Hubei